Original Research

Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model Analysis

Yang H, Li N, Zhou Y, Xiao Z, Tian H, Hu M, Li S

Drug Design, Development and Therapy 2020, 14:157-165

Published Date: 14 January 2020